Share thisshareby e-mailTwitterFacebook
Print thisPrint

June 10, 2021 - ALROSA (Zimbabwe) Limited (ALROSA Zim) provided for Sputnik V coronavirus vaccine delivered to the Ministry of Health and Child Care of Zimbabwe.

ALROSA Zim, a joint venture involving ALROSA and Zimbabwe Consolidated Diamond Company (ZCDC), facilitated the delivery of 25,000 doses of vaccine from Russia to Harare. The second delivery with another 25,000 doses will arrive to Zimbabwe within a month.

'A member of Responsible Jewellery Council, World Diamond Council and Natural Diamond Council, ALROSA is committed to the highest standards of social responsibility and complies with the most strict international industry standards. Supporting local communities in the regions where we operate is one of our top priorities. Year by year we support various social, environmental and charitable programs in the regions where we operate. A joint venture with ZCDC carries prospecting and early exploration works in Zimbabwe since 2020. In these challenging times, ALROSA Zim is donating COVID-19 vaccine kits to the people of Zimbabwe,' said ALROSA Deputy CEO Vladimir Marchenko.

About ALROSA Zim:

ALROSA (Zimbabwe) Limited - ALROSA Zim, - is a joint venture involving ALROSA and Zimbabwe Consolidated Diamond Company (ZCDC). According to the shareholder agreement and a JV establishment agreement, ALROSA controls 70% of ALROSA Zim, while Zimbabwean state-owned diamond mining company's share is 30%. The joint venture focuses on prospecting, exploration and, in case of success, mining of primary diamond deposits in the Republic of Zimbabwe.

About 'Sputnik V' vaccine:
The Gam-COVID-Vac combined vector vaccine developed by the N.F. Gamaleya National Research Center for Epidemiology and Microbiology with support from the Russian Direct Investment Fund was registered by the Russian Ministry of Health in August 2020. The vaccine was named 'Sputnik V' after the first Soviet space satellite that opened a new era in the global space research. Each vaccine kit consists of two doses.

This page was last updated on 10 June 2021 at 09.13
PreviousarticleBack to newslisting

Attachments

  • Original document
  • Permalink

Disclaimer

ALROSA PJSC published this content on 10 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 June 2021 06:19:05 UTC.